share_log

Nanoco Group (LON:NANO) Stock Crosses Below 200 Day Moving Average of $40.16

Defense World ·  Jan 13, 2023 03:33

Nanoco Group plc (LON:NANO – Get Rating) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 40.16 ($0.49) and traded as low as GBX 37 ($0.45). Nanoco Group shares last traded at GBX 37.60 ($0.46), with a volume of 3,029,437 shares changing hands.

Nanoco Group Stock Performance

The company has a quick ratio of 3.57, a current ratio of 3.81 and a debt-to-equity ratio of 91.25. The company's 50-day moving average is GBX 39.54 and its two-hundred day moving average is GBX 40.16. The company has a market capitalization of £121.24 million and a P/E ratio of -26.86.

About Nanoco Group

(Get Rating)

Nanoco Group plc, together with its subsidiaries, engages in the research, development, manufacture, and licensing of novel nanomaterials for use in various commercial applications. The company offers CFQD quantum dots consisting of fluorescent semiconductor nanoparticles for OLED and μLED colour conversion, QD-EL, and security tagging applications; HEATWAVE quantum dots to use in the sensor industry; and VIVODOTS nanoparticles for medical and veterinary applications.

See Also

  • 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
  • Optimism About Global Demand For Metals Boosts BHP, Other Miners
  • Exxon Mobil Expects Earnings and Cash Flow to Grow
  • Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
  • Is The Great Alibaba Recovery About To Begin?

Receive News & Ratings for Nanoco Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanoco Group and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment